Try our beta test site

Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV

This study is ongoing, but not recruiting participants.
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
University of Pennsylvania Identifier:
First received: February 21, 2006
Last updated: August 17, 2016
Last verified: August 2016